UniProt ID | HNRPQ_HUMAN | |
---|---|---|
UniProt AC | O60506 | |
Protein Name | Heterogeneous nuclear ribonucleoprotein Q | |
Gene Name | SYNCRIP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 623 | |
Subcellular Localization |
Cytoplasm . Microsome . Endoplasmic reticulum. Nucleus . The tyrosine phosphorylated form bound to RNA is found in microsomes (By similarity). Localized in cytoplasmic mRNP granules containing untranslated mRNAs (By similarity). Isoform 1: Nucleus, |
|
Protein Description | Heterogenous nuclear ribonucleoprotein (hnRNP) implicated in mRNA processing mechanisms. Component of the CRD-mediated complex that promotes MYC mRNA stability. Isoform 1, isoform 2 and isoform 3 are associated in vitro with pre-mRNA, splicing intermediates and mature mRNA protein complexes. Isoform 1 binds to apoB mRNA AU-rich sequences. Isoform 1 is part of the APOB mRNA editosome complex and may modulate the postranscriptional C to U RNA-editing of the APOB mRNA through either by binding to A1CF (APOBEC1 complementation factor), to APOBEC1 or to RNA itself. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Interacts in vitro preferentially with poly(A) and poly(U) RNA sequences. Isoform 3 may be involved in cytoplasmic vesicle-based mRNA transport through interaction with synaptotagmins. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation; seems not to be essential for GAIT complex function.. | |
Protein Sequence | MATEHVNGNGTEEPMDTTSAVIHSENFQTLLDAGLPQKVAEKLDEIYVAGLVAHSDLDERAIEALKEFNEDGALAVLQQFKDSDLSHVQNKSAFLCGVMKTYRQREKQGTKVADSSKGPDEAKIKALLERTGYTLDVTTGQRKYGGPPPDSVYSGQQPSVGTEIFVGKIPRDLFEDELVPLFEKAGPIWDLRLMMDPLTGLNRGYAFVTFCTKEAAQEAVKLYNNHEIRSGKHIGVCISVANNRLFVGSIPKSKTKEQILEEFSKVTEGLTDVILYHQPDDKKKNRGFCFLEYEDHKTAAQARRRLMSGKVKVWGNVGTVEWADPIEDPDPEVMAKVKVLFVRNLANTVTEEILEKAFSQFGKLERVKKLKDYAFIHFDERDGAVKAMEEMNGKDLEGENIEIVFAKPPDQKRKERKAQRQAAKNQMYDDYYYYGPPHMPPPTRGRGRGGRGGYGYPPDYYGYEDYYDYYGYDYHNYRGGYEDPYYGYEDFQVGARGRGGRGARGAAPSRGRGAAPPRGRAGYSQRGGPGSARGVRGARGGAQQQRGRGVRGARGGRGGNVGGKRKADGYNQPDSKRRQTNNQNWGSQPIAQQPLQGGDHSGNYGYKSENQEFYQDTFGQQWK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATEHVNGN ------CCCCCCCCC | 22.99 | 19413330 | |
13 (in isoform 5) | Ubiquitination | - | 45.84 | 21890473 | |
19 (in isoform 5) | Ubiquitination | - | 23.72 | 21890473 | |
42 | Acetylation | LPQKVAEKLDEIYVA CCHHHHHHCCHHHHH | 52.04 | 26051181 | |
47 | Phosphorylation | AEKLDEIYVAGLVAH HHHCCHHHHHHHHHC | 5.12 | - | |
55 | Phosphorylation | VAGLVAHSDLDERAI HHHHHHCCCCCHHHH | 30.08 | 28348404 | |
66 | Acetylation | ERAIEALKEFNEDGA HHHHHHHHHHCCCCH | 68.27 | 26051181 | |
66 | Ubiquitination | ERAIEALKEFNEDGA HHHHHHHHHHCCCCH | 68.27 | - | |
70 (in isoform 5) | Ubiquitination | - | 64.24 | 21890473 | |
81 | Acetylation | LAVLQQFKDSDLSHV HHHHHHHCCCCCHHH | 52.57 | 25825284 | |
81 | Ubiquitination | LAVLQQFKDSDLSHV HHHHHHHCCCCCHHH | 52.57 | 21906983 | |
81 (in isoform 1) | Ubiquitination | - | 52.57 | 21890473 | |
81 (in isoform 2) | Ubiquitination | - | 52.57 | 21906983 | |
81 (in isoform 3) | Ubiquitination | - | 52.57 | 21890473 | |
81 (in isoform 4) | Ubiquitination | - | 52.57 | 21906983 | |
91 | Ubiquitination | DLSHVQNKSAFLCGV CCHHHCCHHHHHHHH | 26.52 | - | |
92 | Phosphorylation | LSHVQNKSAFLCGVM CHHHCCHHHHHHHHH | 31.63 | 21712546 | |
96 | Glutathionylation | QNKSAFLCGVMKTYR CCHHHHHHHHHHHHH | 2.89 | 22555962 | |
100 | Acetylation | AFLCGVMKTYRQREK HHHHHHHHHHHHHHH | 39.74 | 19608861 | |
100 | Ubiquitination | AFLCGVMKTYRQREK HHHHHHHHHHHHHHH | 39.74 | 19608861 | |
107 | Ubiquitination | KTYRQREKQGTKVAD HHHHHHHHHCCCCCC | 57.10 | - | |
110 | Phosphorylation | RQREKQGTKVADSSK HHHHHHCCCCCCCCC | 21.61 | 22817900 | |
111 | Ubiquitination | QREKQGTKVADSSKG HHHHHCCCCCCCCCC | 42.10 | 21906983 | |
111 (in isoform 1) | Ubiquitination | - | 42.10 | 21890473 | |
111 (in isoform 2) | Ubiquitination | - | 42.10 | 21906983 | |
111 (in isoform 3) | Ubiquitination | - | 42.10 | 21890473 | |
111 (in isoform 4) | Ubiquitination | - | 42.10 | 21906983 | |
115 | Phosphorylation | QGTKVADSSKGPDEA HCCCCCCCCCCCCHH | 24.98 | 29632367 | |
116 | Phosphorylation | GTKVADSSKGPDEAK CCCCCCCCCCCCHHH | 42.02 | 29632367 | |
117 | Acetylation | TKVADSSKGPDEAKI CCCCCCCCCCCHHHH | 77.68 | 26051181 | |
117 | Ubiquitination | TKVADSSKGPDEAKI CCCCCCCCCCCHHHH | 77.68 | 21906983 | |
117 (in isoform 1) | Ubiquitination | - | 77.68 | 21890473 | |
117 (in isoform 2) | Ubiquitination | - | 77.68 | 21906983 | |
117 (in isoform 3) | Ubiquitination | - | 77.68 | 21890473 | |
117 (in isoform 4) | Ubiquitination | - | 77.68 | 21906983 | |
123 | Trimethylation | SKGPDEAKIKALLER CCCCCHHHHHHHHHH | 42.57 | - | |
123 | Acetylation | SKGPDEAKIKALLER CCCCCHHHHHHHHHH | 42.57 | 25953088 | |
123 | Methylation | SKGPDEAKIKALLER CCCCCHHHHHHHHHH | 42.57 | - | |
123 | Ubiquitination | SKGPDEAKIKALLER CCCCCHHHHHHHHHH | 42.57 | 17370265 | |
123 (in isoform 5) | Ubiquitination | - | 42.57 | 21890473 | |
125 | Trimethylation | GPDEAKIKALLERTG CCCHHHHHHHHHHHC | 32.07 | - | |
125 | Methylation | GPDEAKIKALLERTG CCCHHHHHHHHHHHC | 32.07 | - | |
131 | Phosphorylation | IKALLERTGYTLDVT HHHHHHHHCCEEEEC | 25.76 | 21406692 | |
133 | Phosphorylation | ALLERTGYTLDVTTG HHHHHHCCEEEECCC | 11.97 | 21406692 | |
134 | Phosphorylation | LLERTGYTLDVTTGQ HHHHHCCEEEECCCC | 20.16 | 21406692 | |
138 | Phosphorylation | TGYTLDVTTGQRKYG HCCEEEECCCCCCCC | 25.52 | 26074081 | |
139 | Phosphorylation | GYTLDVTTGQRKYGG CCEEEECCCCCCCCC | 31.03 | 26074081 | |
144 | Phosphorylation | VTTGQRKYGGPPPDS ECCCCCCCCCCCCCC | 29.51 | 28152594 | |
151 | Phosphorylation | YGGPPPDSVYSGQQP CCCCCCCCCCCCCCC | 28.82 | 28152594 | |
153 | Phosphorylation | GPPPDSVYSGQQPSV CCCCCCCCCCCCCCC | 15.84 | 28152594 | |
154 | Phosphorylation | PPPDSVYSGQQPSVG CCCCCCCCCCCCCCC | 28.15 | 28152594 | |
159 | Phosphorylation | VYSGQQPSVGTEIFV CCCCCCCCCCCEEEE | 28.92 | 23401153 | |
162 | Phosphorylation | GQQPSVGTEIFVGKI CCCCCCCCEEEEECC | 24.61 | 28464451 | |
168 | Acetylation | GTEIFVGKIPRDLFE CCEEEEECCCHHHHC | 44.21 | 25953088 | |
168 | Sumoylation | GTEIFVGKIPRDLFE CCEEEEECCCHHHHC | 44.21 | 28112733 | |
168 | Ubiquitination | GTEIFVGKIPRDLFE CCEEEEECCCHHHHC | 44.21 | 21906983 | |
168 (in isoform 1) | Ubiquitination | - | 44.21 | 21890473 | |
168 (in isoform 2) | Ubiquitination | - | 44.21 | 21906983 | |
168 (in isoform 3) | Ubiquitination | - | 44.21 | 21890473 | |
168 (in isoform 4) | Ubiquitination | - | 44.21 | 21906983 | |
184 | Ubiquitination | ELVPLFEKAGPIWDL CCHHHHHHHCCHHEH | 51.84 | - | |
184 (in isoform 3) | Ubiquitination | - | 51.84 | - | |
192 | Methylation | AGPIWDLRLMMDPLT HCCHHEHHHHHCCCC | 20.33 | - | |
194 | Sulfoxidation | PIWDLRLMMDPLTGL CHHEHHHHHCCCCCC | 2.01 | 21406390 | |
205 | Phosphorylation | LTGLNRGYAFVTFCT CCCCCCCEEEEEEEC | 8.14 | 28152594 | |
211 | S-palmitoylation | GYAFVTFCTKEAAQE CEEEEEEECHHHHHH | 3.77 | 29575903 | |
213 | Acetylation | AFVTFCTKEAAQEAV EEEEEECHHHHHHHH | 46.68 | 26051181 | |
213 | Methylation | AFVTFCTKEAAQEAV EEEEEECHHHHHHHH | 46.68 | 23644510 | |
221 | Acetylation | EAAQEAVKLYNNHEI HHHHHHHHHHCCCCC | 52.91 | 19608861 | |
221 | Malonylation | EAAQEAVKLYNNHEI HHHHHHHHHHCCCCC | 52.91 | 26320211 | |
221 | Ubiquitination | EAAQEAVKLYNNHEI HHHHHHHHHHCCCCC | 52.91 | 21890473 | |
221 (in isoform 1) | Ubiquitination | - | 52.91 | 21890473 | |
221 (in isoform 2) | Ubiquitination | - | 52.91 | 21906983 | |
221 (in isoform 3) | Ubiquitination | - | 52.91 | 21890473 | |
221 (in isoform 4) | Ubiquitination | - | 52.91 | 21906983 | |
223 | Phosphorylation | AQEAVKLYNNHEIRS HHHHHHHHCCCCCCC | 14.27 | 28152594 | |
232 | Acetylation | NHEIRSGKHIGVCIS CCCCCCCCEEEEEEE | 33.04 | 26051181 | |
238 (in isoform 5) | Ubiquitination | - | 3.27 | 21890473 | |
240 (in isoform 5) | Ubiquitination | - | 3.15 | 21890473 | |
249 | Phosphorylation | NNRLFVGSIPKSKTK CCEEEECCCCCCCCH | 30.34 | 30266825 | |
253 | Phosphorylation | FVGSIPKSKTKEQIL EECCCCCCCCHHHHH | 39.96 | 23312004 | |
255 | Phosphorylation | GSIPKSKTKEQILEE CCCCCCCCHHHHHHH | 47.07 | 27134283 | |
256 | Acetylation | SIPKSKTKEQILEEF CCCCCCCHHHHHHHH | 51.89 | 26822725 | |
256 | Ubiquitination | SIPKSKTKEQILEEF CCCCCCCHHHHHHHH | 51.89 | - | |
258 (in isoform 5) | Ubiquitination | - | 47.31 | 21890473 | |
265 | Ubiquitination | QILEEFSKVTEGLTD HHHHHHHHHHCCCCE | 59.50 | - | |
265 (in isoform 5) | Ubiquitination | - | 59.50 | 21890473 | |
276 | Phosphorylation | GLTDVILYHQPDDKK CCCEEEEEECCCCCC | 6.31 | 28152594 | |
282 | Acetylation | LYHQPDDKKKNRGFC EEECCCCCCCCCCEE | 73.38 | 25953088 | |
282 | Ubiquitination | LYHQPDDKKKNRGFC EEECCCCCCCCCCEE | 73.38 | - | |
283 | Acetylation | YHQPDDKKKNRGFCF EECCCCCCCCCCEEE | 63.37 | 25953088 | |
283 | Ubiquitination | YHQPDDKKKNRGFCF EECCCCCCCCCCEEE | 63.37 | - | |
284 | Ubiquitination | HQPDDKKKNRGFCFL ECCCCCCCCCCEEEE | 58.58 | - | |
286 | Methylation | PDDKKKNRGFCFLEY CCCCCCCCCEEEEEE | 48.74 | - | |
288 (in isoform 5) | Ubiquitination | - | 2.10 | 21890473 | |
289 | Glutathionylation | KKKNRGFCFLEYEDH CCCCCCEEEEEECCH | 4.19 | 22555962 | |
289 | S-palmitoylation | KKKNRGFCFLEYEDH CCCCCCEEEEEECCH | 4.19 | 29575903 | |
293 | Phosphorylation | RGFCFLEYEDHKTAA CCEEEEEECCHHHHH | 28.89 | 28152594 | |
297 | Acetylation | FLEYEDHKTAAQARR EEEECCHHHHHHHHH | 52.78 | 25953088 | |
297 | Malonylation | FLEYEDHKTAAQARR EEEECCHHHHHHHHH | 52.78 | 26320211 | |
297 | Sumoylation | FLEYEDHKTAAQARR EEEECCHHHHHHHHH | 52.78 | - | |
297 | Ubiquitination | FLEYEDHKTAAQARR EEEECCHHHHHHHHH | 52.78 | - | |
308 | Phosphorylation | QARRRLMSGKVKVWG HHHHHHHCCCEEEEE | 39.80 | 24719451 | |
310 | Ubiquitination | RRRLMSGKVKVWGNV HHHHHCCCEEEEECE | 31.41 | - | |
312 | Ubiquitination | RLMSGKVKVWGNVGT HHHCCCEEEEECEEE | 35.44 | - | |
321 (in isoform 2) | Ubiquitination | - | 36.46 | 21906983 | |
321 (in isoform 4) | Ubiquitination | - | 36.46 | 21906983 | |
328 | Acetylation | EWADPIEDPDPEVMA EECCCCCCCCHHHHH | 54.33 | 19608861 | |
328 | Ubiquitination | EWADPIEDPDPEVMA EECCCCCCCCHHHHH | 54.33 | 19608861 | |
328 (in isoform 2) | Ubiquitination | - | 54.33 | 21906983 | |
328 (in isoform 4) | Ubiquitination | - | 54.33 | 21906983 | |
336 | Ubiquitination | PDPEVMAKVKVLFVR CCHHHHHHEEEHHHH | 25.21 | 21906983 | |
336 (in isoform 1) | Ubiquitination | - | 25.21 | 21890473 | |
336 (in isoform 3) | Ubiquitination | - | 25.21 | 21890473 | |
338 | Acetylation | PEVMAKVKVLFVRNL HHHHHHEEEHHHHCH | 32.30 | 24707635 | |
338 | Ubiquitination | PEVMAKVKVLFVRNL HHHHHHEEEHHHHCH | 32.30 | 21890473 | |
338 (in isoform 1) | Ubiquitination | - | 32.30 | 21890473 | |
338 (in isoform 3) | Ubiquitination | - | 32.30 | 21890473 | |
348 | Phosphorylation | FVRNLANTVTEEILE HHHCHHHHCCHHHHH | 24.17 | 23403867 | |
350 | Phosphorylation | RNLANTVTEEILEKA HCHHHHCCHHHHHHH | 26.34 | 23403867 | |
351 (in isoform 2) | Ubiquitination | - | 38.41 | 21906983 | |
351 (in isoform 4) | Ubiquitination | - | 38.41 | 21906983 | |
356 | Acetylation | VTEEILEKAFSQFGK CCHHHHHHHHHHCCC | 51.81 | 26051181 | |
356 | Ubiquitination | VTEEILEKAFSQFGK CCHHHHHHHHHHCCC | 51.81 | 21906983 | |
356 (in isoform 1) | Ubiquitination | - | 51.81 | 21890473 | |
356 (in isoform 3) | Ubiquitination | - | 51.81 | 21890473 | |
363 | Acetylation | KAFSQFGKLERVKKL HHHHHCCCHHHHHHH | 48.76 | 19608861 | |
363 | Malonylation | KAFSQFGKLERVKKL HHHHHCCCHHHHHHH | 48.76 | 26320211 | |
363 | Methylation | KAFSQFGKLERVKKL HHHHHCCCHHHHHHH | 48.76 | 22633583 | |
363 | Ubiquitination | KAFSQFGKLERVKKL HHHHHCCCHHHHHHH | 48.76 | 21890473 | |
363 (in isoform 1) | Ubiquitination | - | 48.76 | 21890473 | |
363 (in isoform 3) | Ubiquitination | - | 48.76 | 21890473 | |
371 | Acetylation | LERVKKLKDYAFIHF HHHHHHHCCEEEEEE | 58.53 | 26051181 | |
371 | Ubiquitination | LERVKKLKDYAFIHF HHHHHHHCCEEEEEE | 58.53 | 21890473 | |
373 | Nitration | RVKKLKDYAFIHFDE HHHHHCCEEEEEEEC | 11.21 | - | |
373 | Phosphorylation | RVKKLKDYAFIHFDE HHHHHCCEEEEEEEC | 11.21 | 12601080 | |
381 | Methylation | AFIHFDERDGAVKAM EEEEEECCCCHHHHH | 49.89 | 115485573 | |
386 | Ubiquitination | DERDGAVKAMEEMNG ECCCCHHHHHHHHCC | 41.29 | 2190698 | |
386 (in isoform 1) | Ubiquitination | - | 41.29 | 21890473 | |
386 (in isoform 3) | Ubiquitination | - | 41.29 | 21890473 | |
394 | Ubiquitination | AMEEMNGKDLEGENI HHHHHCCCCCCCCCE | 54.88 | - | |
394 (in isoform 3) | Ubiquitination | - | 54.88 | - | |
407 | Ubiquitination | NIEIVFAKPPDQKRK CEEEEEECCCCHHHH | 45.69 | - | |
407 (in isoform 3) | Ubiquitination | - | 45.69 | - | |
412 | Acetylation | FAKPPDQKRKERKAQ EECCCCHHHHHHHHH | 73.20 | 24431059 | |
412 | Ubiquitination | FAKPPDQKRKERKAQ EECCCCHHHHHHHHH | 73.20 | - | |
428 | Phosphorylation | QAAKNQMYDDYYYYG HHHHHHCCCCCCCCC | 8.90 | 26846344 | |
431 | Phosphorylation | KNQMYDDYYYYGPPH HHHCCCCCCCCCCCC | 7.17 | 26846344 | |
432 | Phosphorylation | NQMYDDYYYYGPPHM HHCCCCCCCCCCCCC | 9.37 | 26846344 | |
433 | Phosphorylation | QMYDDYYYYGPPHMP HCCCCCCCCCCCCCC | 8.84 | 26846344 | |
434 | Phosphorylation | MYDDYYYYGPPHMPP CCCCCCCCCCCCCCC | 13.67 | 26846344 | |
443 | Phosphorylation | PPHMPPPTRGRGRGG CCCCCCCCCCCCCCC | 52.08 | 26846344 | |
444 | Asymmetric dimethylarginine | PHMPPPTRGRGRGGR CCCCCCCCCCCCCCC | 38.29 | - | |
444 | Methylation | PHMPPPTRGRGRGGR CCCCCCCCCCCCCCC | 38.29 | 23455924 | |
446 | Methylation | MPPPTRGRGRGGRGG CCCCCCCCCCCCCCC | 28.48 | 24395445 | |
448 | Methylation | PPTRGRGRGGRGGYG CCCCCCCCCCCCCCC | 42.93 | 24395453 | |
472 | Phosphorylation | DYYDYYGYDYHNYRG CCCCCCCCCCCCCCC | 9.37 | - | |
474 | Phosphorylation | YDYYGYDYHNYRGGY CCCCCCCCCCCCCCC | 5.40 | - | |
478 | Methylation | GYDYHNYRGGYEDPY CCCCCCCCCCCCCCC | 37.06 | - | |
485 | Phosphorylation | RGGYEDPYYGYEDFQ CCCCCCCCCCCCCCC | 23.11 | 22817900 | |
488 | Phosphorylation | YEDPYYGYEDFQVGA CCCCCCCCCCCCCCC | 9.01 | - | |
496 | Dimethylation | EDFQVGARGRGGRGA CCCCCCCCCCCCCCC | 29.43 | - | |
496 | Methylation | EDFQVGARGRGGRGA CCCCCCCCCCCCCCC | 29.43 | 23455924 | |
498 | Dimethylation | FQVGARGRGGRGARG CCCCCCCCCCCCCCC | 38.55 | - | |
498 | Methylation | FQVGARGRGGRGARG CCCCCCCCCCCCCCC | 38.55 | 24396479 | |
501 | Methylation | GARGRGGRGARGAAP CCCCCCCCCCCCCCC | 38.12 | 115485581 | |
504 | Methylation | GRGGRGARGAAPSRG CCCCCCCCCCCCCCC | 37.80 | 115485589 | |
509 | Phosphorylation | GARGAAPSRGRGAAP CCCCCCCCCCCCCCC | 42.51 | 22817900 | |
510 | Asymmetric dimethylarginine | ARGAAPSRGRGAAPP CCCCCCCCCCCCCCC | 37.46 | - | |
510 | Methylation | ARGAAPSRGRGAAPP CCCCCCCCCCCCCCC | 37.46 | 23455924 | |
518 | Asymmetric dimethylarginine | GRGAAPPRGRAGYSQ CCCCCCCCCCCCCCC | 46.28 | - | |
518 | Methylation | GRGAAPPRGRAGYSQ CCCCCCCCCCCCCCC | 46.28 | 23455924 | |
520 | Methylation | GAAPPRGRAGYSQRG CCCCCCCCCCCCCCC | 26.56 | 115485597 | |
524 | Phosphorylation | PRGRAGYSQRGGPGS CCCCCCCCCCCCCCC | 16.69 | 22817900 | |
526 | Asymmetric dimethylarginine | GRAGYSQRGGPGSAR CCCCCCCCCCCCCCC | 46.20 | - | |
526 | Methylation | GRAGYSQRGGPGSAR CCCCCCCCCCCCCCC | 46.20 | 23455924 | |
531 | Phosphorylation | SQRGGPGSARGVRGA CCCCCCCCCCCCCCC | 20.23 | 22817900 | |
533 | Methylation | RGGPGSARGVRGARG CCCCCCCCCCCCCCC | 45.92 | 24383427 | |
536 | Asymmetric dimethylarginine | PGSARGVRGARGGAQ CCCCCCCCCCCCCCH | 35.56 | - | |
536 | Methylation | PGSARGVRGARGGAQ CCCCCCCCCCCCCCH | 35.56 | 23455924 | |
539 | Asymmetric dimethylarginine | ARGVRGARGGAQQQR CCCCCCCCCCCHHCC | 47.07 | - | |
539 | Methylation | ARGVRGARGGAQQQR CCCCCCCCCCCHHCC | 47.07 | 23455924 | |
565 | Methylation | GGNVGGKRKADGYNQ CCCCCCCCCCCCCCC | 42.54 | - | |
566 | Acetylation | GNVGGKRKADGYNQP CCCCCCCCCCCCCCC | 55.08 | 19829793 | |
566 | Ubiquitination | GNVGGKRKADGYNQP CCCCCCCCCCCCCCC | 55.08 | - | |
570 | Phosphorylation | GKRKADGYNQPDSKR CCCCCCCCCCCCHHH | 15.92 | 28102081 | |
575 | Phosphorylation | DGYNQPDSKRRQTNN CCCCCCCHHHCCCCC | 34.44 | 21815630 | |
576 | Acetylation | GYNQPDSKRRQTNNQ CCCCCCHHHCCCCCC | 60.01 | 7495477 | |
576 | Ubiquitination | GYNQPDSKRRQTNNQ CCCCCCHHHCCCCCC | 60.01 | - | |
580 | Phosphorylation | PDSKRRQTNNQNWGS CCHHHCCCCCCCCCC | 34.03 | 24043423 | |
587 | Phosphorylation | TNNQNWGSQPIAQQP CCCCCCCCCCCCCCC | 25.13 | 17525332 | |
601 | Phosphorylation | PLQGGDHSGNYGYKS CCCCCCCCCCCCCCC | 33.21 | 21712546 | |
607 | Sumoylation | HSGNYGYKSENQEFY CCCCCCCCCCCCCHH | 47.10 | 28112733 | |
614 | Phosphorylation | KSENQEFYQDTFGQQ CCCCCCHHHHCCCCC | 12.53 | 21945579 | |
617 | Phosphorylation | NQEFYQDTFGQQWK- CCCHHHHCCCCCCC- | 17.72 | 21945579 | |
623 | Acetylation | DTFGQQWK------- HCCCCCCC------- | 46.23 | 91213 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
373 | Y | Phosphorylation | Kinase | FGFR1 | P11362 | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HNRPQ_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HNRPQ_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221 AND LYS-363, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-587, AND MASSSPECTROMETRY. | |
"Signaling initiated by overexpression of the fibroblast growth factorreceptor-1 investigated by mass spectrometry."; Hinsby A.M., Olsen J.V., Bennett K.L., Mann M.; Mol. Cell. Proteomics 2:29-36(2003). Cited for: PARTIAL PROTEIN SEQUENCE, MASS SPECTROMETRY, AND PHOSPHORYLATION ATTYR-373. | |
Ubiquitylation | |
Reference | PubMed |
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry."; Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; Proteomics 7:868-874(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-123, AND MASSSPECTROMETRY. |